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POSTER SESSION pared with standard 1 to 1 IABP assist. The recorded data included LV pressure and vol- 
ume (conductance catheter), aortic pressure. left atrial pressure, pulmonarv arterv flow, 
coronary flow and carotid artery flow (ultrasonic flow prdbes). 
1208 Mechanical Assist Devices for Ventricular Results: See table: Means&D: #P<.O5: *Relative changes and significance versus 
Dysfunction 
baseline; ** Relative changes and significance versus baseline AMR; &Absolute 
changes. In the AMR setting the IMP effectively restores cardiac output, coronary perfu- 
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sion and systemic perfusion. The IMP suppresses pulmonary congestion by unloading 
the left atrium. 
Hemodynamic effect of assist 
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1208-65 Favorable Clinical Outcome in Patients With 
Cardiogenic Shock Due to Fulminant Myocarditis 
Supported by Extracorporeal Membrane Oxygenation: 
Comparison With Those With Acute (Nonfulminant) 
Myocarditis 
Yasuhide Asaumi, Satoshi Yasuda, lsao Morii, Hiroyuki Kakuchi, Yoritaka Otsuka, 
Atsushi Kawamura, Hiroshi Nonogi, Yoshikado Sasako, Shunichi Miyazaki, National 
Cardiovascular Center, Suita, Japan 
Background: The application of extracorporeal membrane oxygenation (ECMO) wtth 
percutaneous cardiopulmonary bypass has been recently extended to temporaiy circula- 
tory support in patients with fulminant myocarditis. However, the survival and prognosis 
of patients who are particularly ill remain poorly understood. Methods: Patients with 
myocarditis were divided into the following two groups. Fourteen patients who required 
ECMO for cardiogenic shock were defined as having fulminant myocarditis (F group), 
whereas 13 patients who had acute onset of symptoms but did not have compromised 
hemodynamics were defined as having acute (nonfulminant) myocarditis (non-F group). 
Results: In F group, 10 patients were successfully weaned from ECMO. Therefore, the 
overall survival rate at the time of discharge was 71%. Between patients who died (D) 
and those survived (S) in F group. there were significant differences (PcO.05) in left ven- 
tricular end-diastolic dimension (D:36& vs S:50*2 [mean&EM] mm), end-systolic 
dimension (D:34+6 vs S:45+2mm), wall thickness (D:15+1 vs S:l lilmm). maxCPK-MB 
levels (D:353*145 vs S:120+35U/L) and serum creatinine levels (D:2.1*0.5 vs 
S:l.O+O.lmg/dl). Compared with the non-F group, the fractional shortening in the F group 
was more severely depressed in the acute phase (F:lOil vs non-F:23*3%, P<O.O5), but 
recovered in the chronic phase (F:30*2 vs non-F:33*3%, P=NS). Rates for adverse clin- 
ical events were also similar between the F and non-F groups during the follow-up period 
of 36 months on average. Conclusions: In patients with fulminant myocarditis, a hemo- 
dynamic support using ECMO results in excellent swival. Once a patient recovers from 
inflammatory myocardial damage, the subsequent clinical outcome is favorable, similar 
to that observed in patients with acute (nonfulminant) myocardltis. 
1208-66 In Vitro Evaluation of the Concept of Pericardial 
Pressure Augmentation in Isolated Pig Hearts 
Markus Ferrari, Markus Schlosser, Gerald S. Werner, Hans R. Figulla, Friedrich-Schiller- 
University, Jena. Germany 
Introduction: Acute right heart failure is an unsolved problem in cardiology and cardio- 
vascular surgery. Mechanical circulatory support devices primarily focus on left ventricu- 
lar failure. Assist devices supporting the right ventricle require major surgery for implant, 
and for its explant. Thus, we thought for a method of minimal invasive right ventricular 
support by pericardialpressure augmentation (PPA). 
Methods: For evaluation of the concept of PPA we built a tulip shaped prototype of the 
dewce covering the apical two thirds of the heart. It consists of two elastic foils with a 
helium gas filled space in between which is inflated and deflated by the driving console of 
an intra-aortic balloon pump. The outer non-compliant foil stabilizes the sac. The inner 
sac transfers the pressure augmentation directly to the epicardium therefore to the heaft. 
Due to differences in myocardlal thickness this technique of pericardial compression 
mainly supports the right ventricle. For in-vitro evaluation of this novel technique of PPA 
we tested the concept of PPA in 8 isolated pig hearts. 
Results: Under PPA with 60 I minute we recorded average right ventricular pressures of 
31.3 +I- 4.42 mmHg during systole, and 1.4 +//- 1.60 mmHg during diastole. Left ventricu- 
lar pressures were 23.7 +/- 5.06 mmHg, and 0.7 +/- 1.25 mmHg respectively. An outflow 
of 200 ml I minute through the pulmonary artery was obtained in the artificial circulation. 
Conclusion: This in-vitro evaluation demonstrates the feasibility of pericardial pressure 
augmentation for right ventricular support. The concept of PPA offers an option of mini- 
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Conclusion: Compared to IABP the new catheter based intracardiac pump significantly 
improves cardiac and systemic hemodynamics during acute mitral regurgitation. This 
minipump may fill the gap in the range of cardiac assist devices between standard IAEP 
and current LV assist device alternatives. 
1208-68 Left Ventricular Diastolic Filling Pattern by Passive 
Ventricular Reshaping in Canine Heart Failure 
Abul Kashem Deborah L. Crabbe, Sarmina Hassan, David B. Melvin, Bruce I. Goldman, -1 
William P. Santamore, Temple University, Philadelphia, PA, University of Cincinnati, 
Cincinnati, OH 
Background: End-stage heart failure is associated with significant alterations in left ven- 
tricular (LV) geometry leading to increases in wall stress and reduced LV contractility. 
CardioClaspTM is a passive restraint device designed to normalize LV geometry and 
reduce wall stress. Improvement in wall stress should be associated with improved dias- 
tolic filling parameters. 
Methods: In dogs (n=lO; 22-26 kg) rapid ventricular pacing (210 ppm, week one. to 240 
ppm week 4) induced decompensated heart failure. Hemodynamic data were obtained 
before and after CardioClaspTM placement. FractIonal area of contraction was measured 
by direct epicardial echocardiography at baseline and with CardioClaspTM. Using transe- 
sophageal echocardiography, pulse wave Doppler measurements of standard mitral 
inflow were obtained in a sub-set of animals (n=5). Data represented here are expressed 
as mean&EM. Results: In-viva overall, CardioClasp TM, decreased end-diastolic LV 
anterior-posterior dimension by 21.2 + 3.9%. LV wall stress was sigmficantly reduced by 
26.6 f 2.1% with CardioClasp? In association with these changes in geometry, frac- 
tional area change increased from 21.6 * 3.6 to 29.7 f 6.0 (p=O.O4). In the subset group, 
peak e wave velocity (56.6 * 6.2 vs. 63.9 f 7.6 cm/set; p=O.20) and e/a ratio (2.0 f 0.2 
vs. 2.1 + 0.3; p=O.ll) remained unchanged with CardioClaspTM placement, however, 
deceleration time was increased from 69.4 + 12.1 to 107.0 * 14.3 msec: (p=O.O3), sug- 
gesting changes in LV compliance with the device. Conclusions: CardioclaspTM was 
able to reshape the ventricle and reduce the wall stress. CardioClaspTM is associated 
with a more favorable geometry, improved systolic performance and LV compliance. 
1208-69 First Clinical Experience With the lmpellafi Micropump 
in Patients With Cardiogenic Shock 
mal invasive implantation, and non-surgical removing of a pericardial device. However, Joseoh Dens W. Flameng, P. Sergeant, P. Herijgers, B. Meyns, University Hospitals 
animal experiments and techntcal improvements of the device are required for further Leuven, Leuven, Belgium 
evaluation of this novel technique in the future 
Objectives To assess safetv, feasibilitv and efficacv of the ImoellaB ourno in oatients 
1208-67 New lmpella Intracardiac Minipump Supports the 
Acutely Failing Left Heart Significantly More Effective 
Than lntraortic Balloon Pumping 
.., 
with cardiogenic shock.Background Animal experiments showed left ventricular unload- 
ing and improved haemodynamics with the Impella micro-axial blood pump. Methods 
From January 2001 through April 2002, 12 patients in cardiogenic shock (on maximal 
inotropic support and with IABP in 6 cases) underwent left ventricle unloading with the 
Koen Reesink Andre Dekker, Theo van der Nagel, Erik van der Veen. Vincent van 
Ommen, Yuri Ganushak. Gijs Geskes, Ceclle Soemers, Jos Maessen, Cardiovascular 
Research Institute Maastricht, Maastricht, The Netherlands 
Background: The Impella intracardiac minipump (IMP) is a new, percutaneous LV 
unloading device recently introduced clinically. The IMP features a 6 mm diameter inte- 
grated cannula-pump assembly with a capacity of 4.5 Ilmin for use in trans aortic valve 
position. The efficacy of the IMP has yet to be established. We tested the hypothesis that 
this device can provide more effective left heari support than IABP in acute heart failure. 
Methods: Reversible acute mitral regurgitation (AMR) was induced in calves (n=6) by 
stenting the mitral valve using a vena cava filter. In each animal full IMP assist was com- 
Impella@ micro-axial pump. Four were placed via the femoral artery (PC1 patients) and 6 
directly through the aorta (postcardiotomy heart failure). Mean age was 60 years (range 
43-75), 6 were’ male. Mean CPl$,, level was 5442 U/L (195.17936). Results A stable 
pump flow of 3.6 +I .l Umln. was reached. Mean blood pressure before Impella@support 
was 61.5 *12.7 mmHg and increased to 75 e26.3 after 6 hours and 75.7 ~16.6 mmHg 
(p=O.O36) after 24 hours. Cardiac output increased from 3.6 t1.2 Llmin to 5.7 e1.5 
(p=O.O04) and 5.9 22.0 Lfmln (p=O.Ol) at 6 and 24 hours. Mean pulmonary wedge pres- 
sure decreased from 20.7 e13.2 mmHg to 13.6 +7.3 and 16 k7.4 mmHg at 6 and 24 
hours (NS). Blood lactate levels decreased significantly after 6 hours of support (from 4.1 
k2.9 to 2.1 +1.7 mmollL, p=O.OOS). Free plasma haemoglobin levels were initially high 
(107.7 * 61.7mgldl at 6 hours) and decreased to 50 mgldl afterwards. Eight patients 
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were weaned, four survived (30 days follow-up). Conclusions Left ventricular unloading 1209-61 Physical Training-Induced Reduction of Peripheral 
with the Impella@ pump increases blood pressure and cardiac output in patients with Monocyte-Related Inflammatory Markers Is Associated 
severe cardiogenic shock, resulting in a decrease in blood lactate levels. With Improvement in Endothelial Function of Chronic 
Heart Failure Patients 
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Stamatls Adamopoulos, John T. Parlssis, Dimitrios Karatzas, Christos Kroupis. George 
Karavolias, Katenna Konwitou, Spilios Karas, Dimitrios Kremastinos, Onassis Cardiac 
Surgery Center, Athens, Greece, Amalia Fleming Hospital, Athens, Greece 
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1209-59 Peak V02 and VENCOP Slope in Patients With Heart 
Failure: A Prognostic Comparison 
Sved S. Aslam Ross Arena, Jonathan Myers, Elsa Varughese, Mary Ann Peberdy, 
Virginia Commonwealth University, Medical School of Virginia, Richmond, VA, Stanford 
University, Palo Alto, CA 
Background: Exercise testing with ventilatory expired gas analysis has consistently 
proven to be a valuable tool for risk stratifying patients with chronic heart failure (CHF). 
Peak oxygen consumption (VOd continues to be the standard for assessing prognosis in 
this population. However, it has recently been suggested that the minute ventilation - car- 
bon dioxide production relationship (VENCOZ slope) may be an even more powerful 
predictor of events than peak VO, in CHF. 
Methods: Two hundred and thirty five subjects with CHF underwent exercise testing 
between 3/18/93 to 10119/01. The ability of peak VO, and the VWCO 2 slope to predict 
cardiac-related mortality and hospitalization were examined. 
Results: Mean follow-up time was 33127 months, and the annual mortality rate was 
5.0%. Univariate Cox regression analysis found peak VC& and VWCO 2 slope to both be 
significant predictors of cardiac-related mortality and hospitalization (pcO.001). Multivari- 
ate analysis revealed peak VC$ added additional value to the VWCq slope in predict- 
ing cardiac-related hospitalization, but not mortality. Receiver operating characteristic 
(ROC) curve analysis demonstrated the VWCO, slope to be a significantly better pre- 
dictor of cardiac-related mortality than peak Vq (~~0.05). Although area under the ROC 
curve for the VWCO, slope was greater than peak Vq in predicting cardiac-related 
hospitalization (0.78 vs. 0.73), the difference was not statistically significant (p=O.O8). 
Conclusion: The VENCO, slope is an important predictor of outcomes in CHF. Risk 
stratification is optimized by combming peak VO, with the VWC02 slope. 
1209-60 Correlation of Brain Natriuretic Peptide Release, 
Cardiopulmonary Exercise Testing, and Six-Minute 
Walking Test in Patients With Heart Failure and Cardiac 
Resynchronization Therapy 
Background: Controlled clinical trials have shown the beneficial effects of biventricular 
pacing (BVP) in patients with heari failure (HF) and left bundle branch block. The effect of 
CRT on the hemodynamic response to exercise (ex) have not been studied, yet. 
Methods: Eighteen consecutive patients with chronic HF, QRS duration >150 msec and 
left ventricular ejection fraction (LVEF) < 35% were studied by MUGA and cardiopulmo- 
nary ax test with simultaneous Swan-Ganz cath, before and after 6 months of CRT with 
BVP. 
Aim: To investigate whether the effects of physical training (PT) on serum monocyte- 
related inflammatory markers such as tumor necrosis factor-a (TNF-a), granulcqie-mac- 
rophage colony-stimulating factor (GM-CSF), macrophage chemoanractant protein-l 
(MCP-I), soluble intercellular adhesion molecule-l @ICAM-1) and soluble vascular cell 
adhesion molecule-l (sVCAM-l), are associated with changes in peripheral blood flow 
and endothelial function of patients with chronic heart failure (CHF) 
Methods: Serum levels of these markers were assessed by ELISA in 15 CHF patients 
(ischemic:7, dilated:8, NYHA:II-III. EF:23t3%) before and after a 12.week program of PT 
in a randomlsed crossover design. Peak oxygen uptake (VOPmax) was used to estimate 
functional status of CHF patients and venous occlusion plethysmography to assess 
endothelial function through reactive hyperemia-induced vasodilatation. 
Results: PT produced a significant reduction I” TNF-a (7.2+1 .l vs 4.9eO.9 pgiml, 
pcO.Ol), GM-CSF (26.5+1.9 vs 20.&1.5 pg/ml, pcO.O2), MCP-1 (191+5 vs 175+5 pg/ml, 
pcO.OOl), slCAM-1 (385t29 vs 322i26 ng/ml, pcO.005) and sVCAMI1 (1309*98 vs 
1121&g ng/ml, p<O.O05), as well as an increase in VOPmax (14.8~ 1 vs 16.7+1 ml/kg/ 
min, pcO.01). A significantly higher (54%. ~~0.05) increase in forearm blood flow in 
response to reactive hyperemia was observed after PT (from 2.7~0.3 to 4.3kO.6 ml/100 
ml tissuelmin) compared with 16.7% after detraining (from 2.2kO.5 to 2.5~0.4 ml/l00 ml 
tissuelmin).Significant correlations were found between PT-induced changes in VOPmax 
and molecules slCAM-1 (r=-0.65, pcO.02) and sVCAM-1 (r=-0.60, p<O.O5), as well as 
PT.induced changes in peripheral blood flow and molecules TNF-a (r=-0.56, p<O.O5), 
slCAM-1 (r=-0.54, ~~0.05) and sVCAM-1 (r=-0.68. p&05). A good correlation was also 
found between PT-induced increase in peripheral blood flow and VOPmax (r=O.70, 
P<O.O5). 
Conclusions: PT reduces peripheral monocyie-related inflammatory markers in CHF. 
These immunomodulatory effects of PT may be related with the improvement in exercise 
capacity of CHF patients, possibly by increasing peripheral blood flow and improving 
endothelial function. 
1209-62 Effects of Cardiac Resynchronization With Biventricular 
Pacing on the Symptoms, Left Ventricular Function, and 
Hemodynamic Data of the Patients With Heart Failure 
and Increased QRS Duration 
Marco M&a, Antonio Curnis, Giosue Mascioli, Luca Bontempi, Roberto Procoplo, Lidia 
&lot, Savina Nodari. LIVIO Del Gas, University of Brescia. Brescia, Italy 
Anil M. Sinha Karsten Filzmaier, Dagmar Kunz, Kai U. Markus, Juergen Graf, Ole A. -1 
Breithardt, Peter Hanrath, Christoph Stellbrink, University Hospital Aachen, Aachen, 
Germany 
Background: Brain natnuretic peptide (BNP) levels are elevated in reduced left ventricu- 
lar function. Cardiac resynchronization therapy (CRT) improves cardiac hemodynamics 
Results: After 6 months of BVP LVEF increased from 20+8% to 25c12% (p=O.O3), peak 
and functional status in heart failure patients (pts). We investigated the effects of CRT on 
VO, from 13.69.3 to 14.923.1 ml/kg/min (p=O.O17) and from 50216 to 5&l 1% of maxi- 
BNP levels, cardiopulmonary exercise testing (CPX) and 6 mln walking test (WT) in 
mal predicted values (p=O.O18); VO, at the anaerobic threshold from 9.8i3.3 to 11.k2.7 
mllkglmin (p=O.O19) and the half-time of post-ex Vq recovery shortened from 150+78 to 
these pts. 
Methods: 20 pts (16m, 65+1Oy) with a mean EF 24-t5%, LBBB (QRS 167*25 ms) and 
119+42 sets (p=O.O32). The VWCO slope declined from 44+13 to 39_+13 (p=O.O5). 
CRT were investigated. CPX was performed on a bicycle wth Incremental work load. 
Hemo data in table (’ pcO.05; t p&01) 
Maximum (VOPmax) and oxygen consumption at the anaerobic threshold (V02-AT) 
were measured. WT was performed on 45 m long plain floor. BNP levels were deter- 
mined with the Triage BNP test (Biosite Diagnostics, USA). Data were collected before 
oacemaker imolantation fbaseline) and after 15~8 weeks of CRT (VDD mode). As BNP 
revels are influenced by ienal fun&x, serum creatinine and blood urea n,tr&en (BUN) 
levels were measured simultaneouslv. Results: The effects of CRT on BNP levels. CPX. 
!JVT and renal function are shown I” the table. Correlation coefficient r was calculated as Heart rate, bpm 
Rest Peak exercise 
Baseline BV Pacing Baseline BV pacing 
77214 71210 117+21 107217 
change of values vs BNP levels during CRT (#p<O.O5). 
Conclusion: Chronic CRT leads to a significant decrease in BNP release and improve- 
Cardiac index, Umin/m2 2.2620.57 2.39+0.55’ 3.6911.22 4.2421.447 
ment of exercise capacity. As there is an inverse correlation between change in BNP lev- 
els and CPX parameters, decreasing BNP levels seem to be an indicator for improved 
functional status and therapeutic efficacy of CRT in patients with advanced heart failure 
and LBBB. 
Stroke volume Index. ml/b/ rn2 31211 35112‘ 32ill 40+14t 
Pulmonary wedge pressure, mm Hg 2229 17k9 35_+10 3O+a 
Right atnal pressure, mm Hg 14t_7 l&5 11+6 1125 
Effects of CRT (mean*SD; *p<O 05 vs baseline; #p<O.O5) The change in the peak ax cardiac index (Cl) correlated with that in peak VO, (r = 0.49: p 
= 0.04) and was the only variable predictive of its increase at multiple regression analy- 
sis. 
BNP (pglml) VOP-AT voemax 6 VVT Creatinine BUN Conclusions: BVP is associated with an improvement in resting LVEF. resting and peak 
(mliminlkg) (mllmirvkg) (m) (mg/dl) (@dl) ex stroke volume index and Cl and of maximal ex capacity. The improvement in the LV 
Baseline 525+/-313 10.6+/-2.3 12.9+/-3.2 355+/- 1.5+/-0.5 56+/- systolic function, with an heightened peak ex Cl, contrlbutes to the increase of the ex 
(132.1250) 106 28 capacity. 
CRT 268+/-228’ 12.5+/-2.1’ l&0+/-3.8’ 413+/- 1.6+/-0.7 63+/- 
(63-956) 108’ 29 
Correlation r -0.58# -0.56# -0.16 
vs BNP 
